Search
for

    Sort by

    Research 61–90 of 1000+

    1. Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes Journal of the European Academy of Dermatology and Venereology · 2021 · 24 citations
    2. Health‐related quality of life and well‐being in pediatric patients with alopecia areata and their caregivers International Journal of Dermatology · 2024 · 2 citations
    3. O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation British Journal of Dermatology · 2025
    4. Hair Loss Springer eBooks · 2015
    5. Treatment of pediatric alopecia areata: A systematic review Journal of the American Academy of Dermatology · 2021 · 48 citations
    6. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels The Aging Male · 2008 · 30 citations
    7. Photobiomodulation for the management of hair loss Photodermatology Photoimmunology & Photomedicine · 2020 · 26 citations
    8. Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models Experimental Dermatology · 2018 · 16 citations
    9. Rethinking the classification of alopecia areata Journal of the American Academy of Dermatology · 2018 · 13 citations
    10. The association between rs2476601 polymorphism in PTPN22 gene and risk of alopecia areata Medicine · 2019 · 9 citations
    11. Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study Journal of the American Academy of Dermatology · 2022 · 7 citations
    12. Hair Follicle Melanogenesis Reflected in Hair Pigmentation as a Developmental Factor in Alopecia Areata Skin appendage disorders · 2021 · 3 citations
    13. COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy JAAD case reports · 2022 · 2 citations
    14. Traumatic experiences, dissociative symptoms, and alexithymia in patients with alopecia areata The Journal of Dermatology · 2024 · 1 citations
    15. A new self‐reported measure of disease severity of scalp hair loss in alopecia areata British Journal of Dermatology · 2020 · 1 citations
    16. Association Between Oxidative Stress Biomarkers And Clinical Severity Of Alopecia Areata: A Systematic Review Adolescencia e Saude · 2026
    17. PP405 in Alopecia: An Emerging Molecule worth Investigating Journal of Community Medicine and Health Solutions · 2026
    18. Real-world evidence in alopecia areata treatment: A narrative review Dermatologica Sinica · 2025
    19. Treatment of Alopecia Areata and Its Numerous Possibilities: A Literature Review Journal of Education Health and Sport · 2024
    20. Serum 25 hydroxyvitamin D in non‐scarring alopecia: A systematic review and meta‐analysis Journal of Cosmetic Dermatology · 2023
    21. An Updated in the Management of Alopecia Areata IntechOpen eBooks · 2023
    22. EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments Value in Health · 2023
    23. The potential of regulatory T cell-based therapies for alopecia areata Frontiers in Immunology · 2023
    24. When hair dig into the brain, JAKi , may help! Journal of the European Academy of Dermatology and Venereology · 2026
    25. Attention Balanced Multi-Dimension Multi-Task Deep Learning for Alopecia Recognition Indian journal of science and technology · 2023
    26. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
    27. Two‐dimensional planimetry for alopecia areata severity evaluation compared with severity of alopecia tool: A pilot study Skin Research and Technology · 2023
    28. 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2 Journal of The American Academy of Dermatology · 2022
    29. Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus Dermatologic Therapy · 2007 · 52 citations
    30. The Non-Cosmetic Dermatological Use of Botulinum Neurotoxin IntechOpen eBooks · 2022